Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Yimin Pharmaceutical is a well-established Chinese pharmaceutical manufacturer founded in 1958, specializing in the development and production of chemical drugs and Traditional Chinese Medicines. The company is particularly recognized for its strong portfolio in anesthesiology, producing essential agents such as Propofol, Midazolam, and Etomidate. Beyond anesthetics, it maintains a significant presence in the cardiovascular, cerebrovascular, and psychiatric therapeutic areas. As a subsidiary of the Beijing Pharmaceutical Group, the company operates large-scale, GMP-certified manufacturing facilities in Beijing. Beijing Yimin Pharmaceutical provides a wide range of finished dosage forms, including injections, tablets, and capsules, primarily serving the domestic Chinese healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Yimin Pharmaceutical.